Japan aims to mass-produce humanoid robots by 2027 as Hitachi deploys AI-powered models and the government backs a domestic robotics strategy.

The sweetest monikers for your tiny bestie.

By Arasu Kannagi Basil Feb 23 (Reuters) - Drug developer Generate Biomedicines said on Monday it was targeting a valuation of ...

On Friday, the Motion Picture Association sent its own cease and desist letter to ByteDance, the company behind the ...

Productivity is being lost, because too many teams are drowning in AI slop, and endless “almost useful” drafts that look ...

Ever had an idea for something that looked cool, but wouldn't work well in practice? When it comes to designing things like ...

Generate:Biomedicines plans to raise around $400 million in its initial public offering — a sum that hasn’t been seen for ...

A lone attacker, leveraging commercial AI tools, has breached over 600 organizations globally in just over a month.